Kami Alexander Pekayvaz

Dr. Kami Alexander Pekayvaz serves as a DZHK Junior Research Group Leader at the Department of Internal Medicine I, Faculty of Medicine, Ludwig Maximilian University of Munich. His laboratory investigates the intersection of cardiovascular immunology and thrombosis, with strategic positioning between basic and translational research using advanced immune-profiling techniques and reverse translational models.

Research interests focus on catecholamine-mediated neutrophil-coagulation interplay in septic and sterile cardiovascular inflammation. His work employs single-cell analyses to characterize inflammatory disease settings, with key investigations into:

• Neuro-immune interfaces in thrombosis
• Immunothrombosis mechanisms in atherosclerosis
• Peripheral neuro-immune communication
• Single-cell biology of inflammatory cardiovascular diseases
• Evolutionary relevance of stress-induced thrombotic pathways

His research demonstrates how environmental stressors trigger conserved catecholamine-neutrophil axes that balance pathogen containment against pathological thrombosis.

Major scientific awards include:

• Clinician Scientist of the Year, LMU Klinikum (2025)
• DZHK Junior Research Group Leader (2025)
• Bayer Thrombosis Research Award (2025)
• Rolf-Becker-Preis (2021)

His publication portfolio reveals consistent leadership in immunothrombosis research, with recent articles demonstrating how single-cell approaches uncover monocyte-neutrophil axes in human thrombosis, multiomic signatures in coronary syndromes, and neutrophil plasticity in pathogen defense. His laboratory operates at the critical junction of cardiovascular medicine, immunology, and systems biology, with particular emphasis on translating mechanistic insights into clinical applications for inflammatory cardiovascular conditions.